Company profile
ly Pharma株式会社
This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.
RegBase Evidence Report
Company identity, confirmed enforcement records, Official Gazette notices, and source-review fields for internal due-diligence files.
| Display name | ly Pharma株式会社 | Original name | ly Pharma株式会社 |
|---|---|---|---|
| Corporate Number | Not recorded | Status | Unknown |
| Confirmed enforcement | 0 record(s) | Official Gazette | 1 notice(s) |
| Registry changes | 0 item(s) | Related companies | 0 candidate(s) |
| Latest public record | 30 Jun 2026 | ||
This report summarizes public-source records collected by RegBase. It is not a credit opinion, sanctions result, legal conclusion, or procurement approval. Verify material findings against the linked original Japanese source before relying on them.
| English display | ly Pharma株式会社 (Japanese original) |
|---|---|
| Japanese name | ly Pharma株式会社 |
| Address | 徳島県徳島市川内町宮島錦野三七番地の五Delta-F |
| Representative | Not recorded |
| Industry | Not recorded |
| Official website | Not recorded |
| Target URL | https://regbase.jp/en/company/f5eb9a3f-81f5-4a68-9015-bfe5292b8029 |
|---|---|
| Regulatory enforcement disclosures | No confirmed linked record in RegBase monitored coverage |
| Official Gazette notices | 1 notice(s) linked in RegBase coverage |
| Registry-source timestamps | Corporate Number site: not recorded / gBizINFO: not recorded / EDINET: not recorded |
No confirmed enforcement record is currently linked to this company in RegBase monitored sources.
| Citation | 30 Jun 2026 Main Edition 第1737号 p.31 |
|---|---|
| Published name | ly Pharma株式会社 |
| Address / court | 徳島県徳島市川内町宮島錦野三七番地の五Delta-F |
| Excerpt | This is a financial statement notice announcing the reduction of capital and capital reserve by Delta-Fly Pharma Corporation as of June 30, 2026. Creditors are advised to respond within one month. |
| Original sources checked | |
|---|---|
| Reviewer / date | |
| Internal notes |
Current page: Company profile
This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.
Free report
Includes company identity, enforcement history, Official Gazette notices, source-review fields, and reviewer notes for internal due-diligence files.
Related tool Kiroku
Open Kiroku monitoring and enter the official website, terms, IR, pricing, or announcement URL you want to track.
You do not need this for normal browsing. Use it when integrating this company record into an internal tool or AI workflow.
Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.
Official Gazette
Delta-Fly Pharma Corporation Capital and Reserve Reduction Notice
Capital and reserve reduction noticeCorporate financial notice第 １７３７ 号 令和８年６月３０日火曜日 官 報 （本 紙） 公 告 会社その他の公告資本金及び準備金の額の減少公告 page="0031" 当社は、資本金の額を五十七億七千二百九十七万千三百六十一円、資本準備金の額を五十七億八千四百二十六万八千百九十七円減少することにいたしました。 この決定に対し異議のある債権者は、本公告掲載の翌日から一箇月以内にお申し出下さい。 なお、最終貸借対照表の開示状況は次のとおりです。 金融商品取引法による有価証券報告書提出済。 令和八年六月三十日徳島県徳島市川内町宮島錦野三七番地の五Delta-Fly Pharma株式会社 代表取締役 江島 淸 ©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.
No enforcement records are currently listed in RegBase's monitored sources.
RegBase automatically collects public disclosures from Japanese government sources. Non-public administrative guidance, oral warnings, and unpublished actions are not included. See data sources.
About this English name
No official English name source is recorded. The original Japanese name is shown.
If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.
This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.